AssayQuant Technologies, Inc.

We’re excited to introduce KinSight Kinome Profiling Services. Learn how profiling with a continuous assay and our detailed enzymological reports provide informative and actionable kinetic insights for your kinase drug discovery hubs.ly/Q01SLXL80 #kinomeprofiling #cancer

Context matters. That is why we created PhosphoSens-Lysate Assays –quantitative kinase activity insights where biology happens. hubs.ly/Q035qBym0 #KinaseInhibitor

Don’t miss Dr. Earl May's panel at the #CellSignalingSymposium! Date/Time: Feb 19th | 2:55-4:25 PM Location: Fairmont Hotel Vancouver Topic: Continuous Enzymatic Assays for Drug Discovery Connect with us to talk kinase kinetics & PhosphoSens® insights! #CellSignaling

Join Dr. Earl May at the Cell Signaling Symposium on Feb 19 in Vancouver! Time: 2:55–4:25 PM Topic: A Continuous Enzymatic Assay Identifies and Characterizes Kinetic Modes of Action to Drive Drug Discovery Discover the latest in cell signaling research! hubs.ly/Q036PzKs0

Just dropped: PhosphoSens-Lysate Assays - real-time, direct fluorescence intensity measurement of kinase activity in crude cell lysates. Order MAPK1/ERK2 and MAPK3/ERK1 assays now, more targets coming soon! hubs.ly/Q035qBT-0 #BiotechTools

Continuous fluorogenic assays = real-time, quantitative kinase & phosphatase activity insights. Learn how this add & read technology is accelerating drug discovery at the Kinase Inhibitor Summit on February 11th at 10 am EST with Dr. Erik Schaefer. #KinaseInhibitorSummit

Heading to the Kinase Inhibitor Summit? Don’t miss Dr. Erik Schaefer as he presents: Continuous Fluorogenic Assays for Kinase & Phosphatase Activity to Enable Drug Development February 11th at 10 am EST | Boston, MA #KinaseInhibitorSummit #DrugDiscovery

Target in focus: ERK1/2 PhosphoSens-Lysate Assays are here to accelerate your kinase research. More targets coming soon! hubs.ly/Q035qDvX0 #BiotechBreakthrough

Looking for real-time kinase activity insights in complex samples? Introducing PhosphoSens-Lysate Assays! Assay MAPK1/ERK2 and MAPK3/ERK1 in their native environments. Additional targets coming soon. hubs.ly/Q035qBNn0 #BiotechInnovation

Announcing PhosphoSens-Lysate Assays: Measure kinase activity in real-time, directly in complex biological samples. Available now for MAPK1/ERK2 and MAPK3/ERK1! hubs.ly/Q035qBsL0 #DrugDiscovery

Get more accurate kinase activity data with PhosphoSens®. Say goodbye to endpoint assays and hello to complete progress curves! hubs.ly/Q034cWl-0 #drugdiscovery #kinase

Maximize your resources! PhosphoSens® reduces the need for multiple assays, saving you time and money. Learn more: hubs.ly/Q034cXGk0 #drugdiscovery #technology #assay

Tired of compound interference in your kinase assays PhosphoSens®-Red's red-shifted fluorescence minimizes interference for cleaner HTS data. Learn more! hubs.ly/Q034cZsx0 #SLAS2025 #drugdiscovery #kinase

Happy Holidays from Assay Quant. We’re celebrating with Kinome Trees! Transform complex kinase inhibition data into clear, publication-ready visualizations. hubs.ly/Q02Y_6Gc0

Three steps to perfect (and festive) kinome trees: 1. Upload data 2. Choose theme 3. Generate & export Happy Holidays from Assay Quant! hubs.ly/Q02Y_w710

It’s the perfect time of year to create, customize, and download high-resolution kinome trees for your next publication or presentation. Get started for free: hubs.ly/Q02Y_w7-0 #SciComm

Endpoint assays do not reveal saturation kinetics. Saturation analysis can identify slow-binding or irreversible inhibition and quantify potency specific to that inhibitor type.   See what you could be missing: hubs.ly/Q02Y6xlw0 #drugdiscovery #kinaseinhibitors

Are you able to recognize saturation in your progress curves?  Endpoint assays do not reveal saturation kinetics. With a continuous assay, you can identify and diagnose saturation in your progress curves. See what you could be missing: hubs.ly/Q02Y6WV_0

Create your own beautiful, customizable kinome trees in minutes. Our free gift to you this Holiday Season: hubs.ly/Q02Y_yQp0 #SciComm

Are you missing progress curve lags? Lag times can expose issues and provide critical insights. Endpoint assays miss them and underestimated potency.  Learn how continuous assays expose lag time and provide critical insights for #drugdiscovery: hubs.ly/Q02Y6KmZ0

What’s more festive than a Kinome Tree?! Zoom into specific kinase families for detailed analysis or view the complete kinome landscape. hubs.ly/Q02Y_F6D0 #SciComm